CN118161435B - Wrinkle removing and resisting composition containing coastal cress tissue culture - Google Patents
Wrinkle removing and resisting composition containing coastal cress tissue culture Download PDFInfo
- Publication number
- CN118161435B CN118161435B CN202410208886.2A CN202410208886A CN118161435B CN 118161435 B CN118161435 B CN 118161435B CN 202410208886 A CN202410208886 A CN 202410208886A CN 118161435 B CN118161435 B CN 118161435B
- Authority
- CN
- China
- Prior art keywords
- wrinkle
- parts
- extract
- cress
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 66
- 230000037303 wrinkles Effects 0.000 title claims abstract description 25
- 244000211187 Lepidium sativum Species 0.000 title claims abstract description 15
- 235000007849 Lepidium sativum Nutrition 0.000 title claims abstract description 15
- 239000000284 extract Substances 0.000 claims abstract description 38
- 206010020649 Hyperkeratosis Diseases 0.000 claims abstract description 29
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000000706 filtrate Substances 0.000 claims abstract description 20
- 241000218691 Cupressaceae Species 0.000 claims abstract description 14
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 claims abstract description 13
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 claims abstract description 12
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- IHRKJQSLKLYWBQ-QKDODKLFSA-N (2s)-2-[[(2s)-1-[(2s)-5-amino-2-[[2-(hexadecanoylamino)acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O IHRKJQSLKLYWBQ-QKDODKLFSA-N 0.000 claims abstract description 11
- 235000017334 Alcea rosea Nutrition 0.000 claims abstract description 11
- 235000017303 Althaea rosea Nutrition 0.000 claims abstract description 11
- BYUQATUKPXLFLZ-UIOOFZCWSA-N CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 BYUQATUKPXLFLZ-UIOOFZCWSA-N 0.000 claims abstract description 11
- 229940093441 palmitoyl oligopeptide Drugs 0.000 claims abstract description 11
- 229940094946 palmitoyl tetrapeptide-7 Drugs 0.000 claims abstract description 11
- 229930003799 tocopherol Natural products 0.000 claims abstract description 10
- 229960001295 tocopherol Drugs 0.000 claims abstract description 10
- 239000011732 tocopherol Substances 0.000 claims abstract description 10
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 10
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 10
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims abstract description 9
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 4
- 240000000530 Alcea rosea Species 0.000 claims abstract 3
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- 230000001153 anti-wrinkle effect Effects 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- -1 alkyl glucoside Chemical class 0.000 claims description 9
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 239000003995 emulsifying agent Substances 0.000 claims description 6
- 239000003906 humectant Substances 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 230000002335 preservative effect Effects 0.000 claims description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 229920006037 cross link polymer Polymers 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 229930182478 glucoside Natural products 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 229960005150 glycerol Drugs 0.000 claims description 3
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 3
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 3
- 229940032094 squalane Drugs 0.000 claims description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 2
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 2
- 229960005323 phenoxyethanol Drugs 0.000 claims description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 229930003427 Vitamin E Natural products 0.000 abstract description 7
- 239000002537 cosmetic Substances 0.000 abstract description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract description 7
- 230000002195 synergetic effect Effects 0.000 abstract description 7
- 239000011709 vitamin E Substances 0.000 abstract description 7
- 235000019165 vitamin E Nutrition 0.000 abstract description 7
- 229940046009 vitamin E Drugs 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 6
- 241000628997 Flos Species 0.000 abstract description 4
- 239000000419 plant extract Substances 0.000 abstract description 4
- 238000013329 compounding Methods 0.000 abstract description 2
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 30
- 210000003491 skin Anatomy 0.000 description 24
- 239000000243 solution Substances 0.000 description 17
- 239000000523 sample Substances 0.000 description 15
- 238000002835 absorbance Methods 0.000 description 12
- 230000008859 change Effects 0.000 description 10
- 241000921356 Alcea Species 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 102000016387 Pancreatic elastase Human genes 0.000 description 6
- 108010067372 Pancreatic elastase Proteins 0.000 description 6
- 102000012422 Collagen Type I Human genes 0.000 description 5
- 108010022452 Collagen Type I Proteins 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 238000007619 statistical method Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 4
- 240000007087 Apium graveolens Species 0.000 description 4
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 4
- 235000010591 Appio Nutrition 0.000 description 4
- 241000125183 Crithmum maritimum Species 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 229930182486 flavonoid glycoside Natural products 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- YLWQTYZKYGNKPI-HMGRVEAOSA-N 3,5,7-trihydroxy-2-[4-hydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=CC=C1O YLWQTYZKYGNKPI-HMGRVEAOSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 240000005980 Eryngium maritimum Species 0.000 description 2
- 235000003933 Eryngium maritimum Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 244000234281 Tamarix gallica Species 0.000 description 2
- 235000014265 Tamarix gallica Nutrition 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000007933 dermal patch Substances 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- RJZNPROJTJSYLC-LLINQDLYSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O RJZNPROJTJSYLC-LLINQDLYSA-N 0.000 description 1
- 235000006578 Althaea Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108700016947 Bos taurus structural-GP Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 244000130592 Hibiscus syriacus Species 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 241000083902 Rhodiola sachalinensis Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241001145025 Saussurea involucrata Species 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- YLWQTYZKYGNKPI-UHFFFAOYSA-N UNPD13421 Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=CC=C1O YLWQTYZKYGNKPI-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 239000002530 phenolic antioxidant Substances 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 238000001521 two-tailed test Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
The invention belongs to the field of cosmetic preparations, and particularly relates to a wrinkle removing and resisting composition containing a coastal cress tissue culture. The composition comprises the following components: coastal cress callus culture filtrate, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7, acetyl hexapeptide-8, tocopherol, dipotassium glycyrrhizinate; the method also comprises the following steps: flos Althaeae Roseae extract and herba Cypress branch extract. The wrinkle-removing and wrinkle-removing composition disclosed by the invention has certain effects of tightening skin, removing wrinkles and resisting wrinkles, and has good synergistic effect by compounding the littoral cress callus culture filtrate, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7, acetyl hexapeptide-8, tocopherol (vitamin E) and dipotassium glycyrrhizinate with plant extract composition hollyhock flower extract and water cypress branch extract.
Description
Technical Field
The invention belongs to the field of cosmetic preparations, and particularly relates to a wrinkle removing and resisting composition containing a coastal cress tissue culture.
Background
Callus refers to tissue which is newly grown on the surface of a wound after the local part of the plant body is stimulated by the wound. Generally refers to tissue in plants that consists of parenchyma cells and does not form a specific structure, and is usually found at the wound of the plant. Modern researches have found that plant callus contains various active functional components, and has been well accepted and applied in the fields of medicine, cosmetics and the like because of good safety and reliability. For example, the tobacco callus extract has the effects of resisting acne and treating glaucoma, the saussurea involucrata callus extract has the effects of resisting tumor, the xanthium sibiricum callus extract has the effects of inhibiting bacteria, and the rhodiola sachalinensis callus has the effects of resisting oxidation.
However, the research degree of the callus extract is limited, and no report on the synergistic effect of the callus extract combined with other components exists. Accordingly, it is desirable to provide a composition containing coastal cress callus culture filtrate that is excellent in performance.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide a composition containing coastal cress callus culture filtrate and application thereof. The composition generates a certain synergistic effect through the cooperation of the plant callus extract and other components, and achieves remarkable effects of removing wrinkles, resisting oxidization and aging.
In order to achieve the above purpose, the present invention discloses the following technical solutions:
In a first aspect, the invention provides a composition comprising the following components in parts by weight:
Further, the composition comprises the following components in parts by weight:
still further, the composition also comprises: flos Althaeae Roseae extract and herba Cypress branch extract.
Further preferably, the hollyhock flower extract is 0.12-0.15 parts by mass; the water cypress branch extract is 0.5-1 part.
In a second aspect, the present invention provides a wrinkle-reducing, anti-wrinkle skin-resident formulation comprising the composition of the first aspect.
Further, the composition of the first aspect is added to the wrinkle-removing and anti-wrinkle skin resident agent in an amount of 0.17% -1.7% by mass.
Further, the skin resident agent for removing the wrinkles and resisting the wrinkles further comprises an emulsifying agent, a preservative, a humectant, a pH regulator and a solvent.
Further, the emulsifier is at least one of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, C14-22 alcohol and C12-20 alkyl glucoside.
Further, the humectant is at least one of glycerin, sodium hyaluronate, squalane, butanediol and 1, 2-hexanediol;
the preservative is at least one of p-hydroxyacetophenone, phenoxyethanol and ethylhexyl glycerol;
The pH regulator is at least one of arginine, sodium hydroxide and disodium hydrogen phosphate.
In a third aspect, the present invention provides a method for preparing the wrinkle-removing and anti-wrinkle skin resident agent according to the second aspect, comprising the following steps:
(1) Heating a certain amount of preservative, humectant, emulsifier and solvent to 65-85deg.C for dissolving, stirring, homogenizing and mixing, and maintaining the temperature for 20min or more to obtain a mixture;
(2) Cooling the mixture obtained in the step (1) to 40-50 ℃, adding the composition according to any one of claims 1-4 into the mixture, dissolving, stirring, mixing, adding a pH regulator, and regulating the pH value to obtain the skin residence agent for removing wrinkles.
In the invention, the following components are added:
The coastal cress callus culture filtrate can effectively promote the natural generation of skin collagen, elastic fiber and other active proteins.
Palmitoyl tripeptide-1 can promote the synthesis of extracellular cytoplasm such as type I and III collagen, elastin and structural glycoprotein such as laminin and fibronectin, promote wound restoration, promote the upgrading and reconstruction of the surface layer of skin, make the skin more compact and elastic, and simultaneously facilitate the repair of the skin after ultraviolet irradiation.
The palmitoyl tetrapeptide-7, palmitoyl tripeptide-1 and acetyl hexapeptide-8 are used in a compound way, so that the synergistic effect is achieved, the generation of interleukin IL-6 in keratinocytes and fibroblasts caused by external injury and ultraviolet is effectively reduced, inflammatory reaction is reduced, skin elasticity is protected and stable, and skin aging is delayed.
Acetyl hexapeptide-8, also called argireline, botulinum-like, etc., is a small molecule protein composed of six amino acids, and has the effects of mainly removing wrinkles, promoting collagen production, repairing damaged skin, and improving cellular metabolism.
The tocopherol is an important phenolic antioxidant, can prevent lipid peroxidation, protect the integrity of cell membranes, reduce the damage of ultraviolet rays to skin, has anti-aging effect, and can promote metabolism of skin and improve moisture and elasticity of skin.
The main chemical components in the hollyhock flower extract comprise flavone and flavonoid glycoside compounds, wherein the flavonoid glycoside compounds comprise quercetin, hyperoside, myricetin-3 '-O-beta-D-glucoside, quercetin-3' -glucoside and the like, and the flavonoid glycoside compounds are very excellent antioxidant components, have higher antioxidant capacity than vitamin C and vitamin E, and can help to remove free radicals and delay aging.
The extract of herba Cypress has positive effects of balancing skin oil secretion, relieving acne, etc., and enhancing transdermal absorption rate. After the water cypress branch extract and the hollyhock flower extract are compounded and used, the wrinkle removing and resisting effects of skin on the composition coastal cress callus culture filtrate, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7 and acetyl hexapeptide-8 can be improved under the condition of the same dosage.
The invention has the beneficial effects that:
1. The wrinkle removing and resisting composition containing the littoral celery callus culture filtrate provided by the invention has good effects of tightening skin, removing wrinkles and resisting wrinkles;
2. The coastal thorny celery callus culture filtrate, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7, acetyl hexapeptide-8, tocopherol (vitamin E) and dipotassium glycyrrhizinate are compounded with the plant extract composition hollyhock flower extract and the water cypress branch extract, so that the invention has good synergistic effect, and the wrinkle removing and resisting effects of the skin resident agent formula are improved.
Detailed Description
For a better description of the objects, technical solutions and advantages of the present invention, the present invention will be further described with reference to the following specific examples. It will be appreciated by persons skilled in the art that the specific embodiments described herein are for purposes of illustration only and are not intended to be limiting.
The test methods used in the specific embodiments are all conventional methods unless otherwise specified; materials, reagents, and the like used, unless otherwise specified, are commercially available; the percentages mentioned in the detailed description are mass percentages unless otherwise indicated.
In the invention, the following components are added:
The coastal cress callus culture filtrate was coastal cress (ERYNGIUM MARITIMUM) callus culture filtrate, INCI name ERYNGIUM MARITIMUM CALLUS CULTURE FILTRATE, available from SEPPIC, france.
The sea fennel callus culture filtrate was sea fennel (CRITHMUM MARITIMUM) callus culture filtrate, INCI name CRITHMUM MARITIMUM CALLUS CULTURE FILTRATE, available from SEPPIC, france.
The EXTRACT of herba Cypress is EXTRACT of herba Cypress (MYRICARIA GERMANICA), INCI named MYRICARIA GERMANICA EXTRACT, available from Shaanxi Sihai Biotechnology Co.
The flos Althaeae Roseae extract is flos Althaeae Roseae (ALTHAEAROSEA) extract, INCI name ALTHAEA ROSEAFLOWER EXTRACT, available from Shaanxi Sisea Biotechnology Co.
Other raw materials are available commercially.
Preparation of wrinkle-removing and anti-wrinkle composition
The raw materials are weighed according to the mass parts in the table 1, and then stirred and mixed uniformly to obtain the anti-wrinkle composition.
Table 1 raw materials for preparing the anti-wrinkle composition
Note that: the raw materials in the table are in parts by mass, "-" means not added.
Preparation of skin resident agent containing anti-wrinkle composition
Step (1), taking acrylic acid (ester)/C10-30 alkanol acrylate crosslinked polymer, glycerin, sodium hyaluronate, dipotassium glycyrrhizinate and water according to the mass parts of table 2, stirring and heating to 85 ℃, preserving heat for 20 minutes, and stirring and dissolving completely to obtain a mixture a;
step (2), taking C14-22 alcohol, C12-20 alkyl glucoside, squalane and tocopherol (vitamin E), heating to 80 ℃, stirring and dissolving completely, and preserving heat for 10 minutes to obtain a mixture b;
Step (3), adding the mixture a and the mixture b into an emulsifying pot, stirring at 80 ℃, homogenizing until complete emulsification is uniform, and obtaining a mixture c;
step (4), cooling the mixture c to 65 ℃, adding butanediol, 1, 2-hexanediol and p-hydroxyacetophenone, and stirring until the mixture is completely and uniformly dispersed to obtain a mixture d;
Step (5), cooling the mixture d to 45 ℃, sequentially adding palmitoyl tripeptide-1, palmitoyl tetrapeptide-7, acetyl hexapeptide-8, coastal thorn celery callus culture filtrate, hollyhock flower extract and water cypress branch extract, and stirring until the mixture is completely and uniformly mixed to obtain a mixture e;
And (6) cooling the mixture e to 38 ℃, adding arginine dissolved in water in advance, and regulating the pH value to be more than or equal to 6.5 to obtain the skin resident agent for removing the wrinkles.
TABLE 2 raw materials for skin resident agent
Performance test:
inhibition of elastase assay
The test uses porcine pancreatic elastase as a test subject and N-succinyl-alanine-p-nitroaniline (AAAPVN) as a substrate. The porcine pancreatic elastase can hydrolyze AAAPVN, and the hydrolysis product can cause the increase of absorbance at 420nm wavelength, and the absorbance is measured by an enzyme-labeled instrument, so that the tightening and anti-wrinkle effects of the sample to be measured can be evaluated.
1. Solution preparation
(1) Sample to be measured: the above prepared wrinkle-removing and wrinkle-resisting compositions 1-7 are respectively taken.
(2) Tris-HCl buffer (0.1M PH=8.0) was prepared: 2.42gTris was weighed into a beaker, 200mL of ultrapure water was added, and after dissolution was completed, the pH was adjusted to 8.0 with concentrated HCl.
(3) Configuration of positive control tea polyphenol solution (1 mg/ml): 5mg of tea polyphenols were weighed and dissolved in 5ml of Tris-HCl buffer.
(4) Substrate solution AAAPVN (2 mM) was prepared: 4.51mg of N-succinyl-alanine-p-nitroaniline are weighed out and dissolved in 5ml of Tris-HCl buffer.
(5) Porcine pancreatic elastase solution (0.171U/mL) was prepared: mu.l of the solution was dissolved in 10ml of Tris-HCl buffer.
2. Grouping and sampling
The test is divided into 4 groups, namely a sample group to be tested, a positive control group, a blank control group and a model control group, and 4 compound holes are arranged under the same concentration of the same group. The amounts of each solution added are shown in Table 3.
Table 3 test group
3. Measurement method
The reaction was allowed to stand at room temperature for 15min, and the absorbance was measured at 420nm with a microplate reader.
4. Calculation formula
Wherein: average value of absorbance of a 0 -blank wells;
A 1 -average value of absorbance of sample wells;
Average value of absorbance of a 2 -model control wells.
5. Statistical method
Statistical analysis was performed using the SPSS22.0 statistical software package to descriptive statistics of the measurements of the test area. The change in the analytical value was calculated and the difference between the control group and the sample group. If the test data are normally distributed, adopting an independent T test method to carry out statistical analysis; if the test data are in non-normal distribution, adopting a rank sum test method to carry out statistical analysis. The statistical methods all use a two-tailed test with a test level α=0.05.
6. Experimental results
TABLE 4 results of porcine pancreatic elastase inhibition rate
Promote type I collagen synthesis assay
In the test, fibroblasts are taken as a detection object, a cell photoaging damage model is established through UVA irradiation, the change of the content of type I Collagen (Collagen I) after the action of a sample to be detected is detected, and the tightening and anti-wrinkle effects of the sample to be detected are evaluated.
(1) Inoculating: cells were seeded at a seeding density of 1×10 4 cells/well into 96-well plates and incubated overnight in an incubator (37 ℃, 5% co 2).
(2) UVA irradiation: after washing the cells with PBS, the groups with UVA irradiation were subjected to UVA irradiation of 30J/cm 2 according to the experimental group of Table 5.
(3) Preparing liquid: compositions 1-7 were selected as test sample solutions, respectively, and experiments were performed using TGF-beta (concentration 100 ng/mL) as a positive control. 100 μl was loaded per well, and 3 duplicate wells were set per group. After the completion of the administration, the 96-well plate was placed in an incubator at 37℃and incubated for 24 hours in the dark.
TABLE 5 grouping of experiments
(4) Cell supernatant collection: taking out the 96-well plate 24h after administration, respectively collecting cell supernatant corresponding to each sample group into a centrifuge tube, centrifuging at 1000rpm for 10min, collecting supernatant, placing the supernatant into a 1.5mL centrifuge tube, and storing at-20 ℃ for later use.
(5) ELISA kit for determining type I collagen concentration in cell supernatant: taking out the kit and the sample to be tested 30min before testing, and placing the kit and the sample to be tested at room temperature for use, wherein the testing operation is strictly operated according to the instruction of the kit.
TABLE 6 type I collagen content test results
Antioxidant test (DPPH radical scavenging)
(1) Test design
Preparing DPPH into 2X 10 -4 mol/L solution with absolute ethyl alcohol, preparing 2mL of each of the solution to be detected, the absolute ethyl alcohol and the DPPH solution as 2-7 parts by taking the composition as the solution to be detected, respectively uniformly mixing, standing at room temperature for 30 minutes, measuring absorbance at a wavelength of 517nm to obtain Ai, measuring each sample in parallel for 3 times, and taking an average value.
Vc is used as a positive control, absolute ethyl alcohol is used for replacing DPPH to measure absorbance value to be used as a control Aj blank, and DPPH solution and absolute ethyl alcohol are mixed to measure absorbance Ac.
The clearance of DPPH radicals from each sample to be tested was calculated according to the following formula (1) and recorded in the following table 7.
Clearance (%) = (1- (Ai-Aj)/Ac) ×100%........... (1)
Wherein: ai is absorbance of 2mL of the mixed solution of the liquid to be detected and the reagent of 2 mLDPPH; aj is absorbance of 2mL of to-be-detected liquid and 2mL of absolute ethyl alcohol mixed liquid; ac is the absorbance of a 2mLDPPH solution+2 mL absolute ethanol mixture.
TABLE 7DPPH clearance rate
Group of | DPPH clearance rate |
Composition 1 | 73.14% |
Composition 2 | 76.41% |
Composition 3 | 72.37% |
Composition 4 | 43.63% |
Composition 5 | 66.34% |
Composition 6 | 63.71% |
Composition 7 | 32.11% |
Analysis of results
1. According to the test result, the anti-wrinkle composition has certain effects of tightening skin and removing wrinkles;
2. According to the test results, the coastal thorny celery callus culture filtrate, the palmitoyl tripeptide-1, the palmitoyl tetrapeptide-7, the acetyl hexapeptide-8, the tocopherol (vitamin E) and the dipotassium glycyrrhizinate in the anti-wrinkle composition have the effect of promoting skin repair together with the hollyhock flower extract and the water cypress branch extract which are plant extract compositions, and under the synergistic effect, the capability of inhibiting the activity of elastase can be effectively improved, the synthesis of skin collagen can be promoted, and the scavenging effect on free radical ions can be enhanced;
3. From the test results, it is clear that the addition amounts of the functional components (coastal cress callus culture filtrate, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7, acetyl hexapeptide-8, tocopherol (vitamin E), dipotassium glycyrrhizinate, hollyhock flower extract and water cypress branch extract) of the composition 2 in the compositions 1, 2 and 3 have the optimal performance compared with other compositions.
Skin resident agent examples 1-4 efficacy test
Stability test:
1. Heat resistance test: the temperature of the constant temperature incubator is regulated to 40 ℃, the prepared examples are respectively used as 4 groups of samples, three samples of each group are taken and are filled in transparent glass bottles, the sample filling amount is 20 ml/bottle, the samples are placed in the constant temperature incubator after being sealed, and the samples are taken out after three months, are restored to room temperature, and are observed for appearance change.
2. Cold resistance test: and (3) regulating the temperature of the constant temperature incubator to-10 ℃, taking three samples from each group, filling the three samples into transparent glass bottles, sealing the bottles with the sample filling quantity of 20 ml/bottle, putting the bottles into the constant temperature incubator for three months, taking out the bottles, recovering the bottles to room temperature, and observing the appearance change.
3. And (3) normal temperature test: and (3) putting the 4 groups of samples into transparent glass bottles, wherein the sample loading amount is 20 ml/bottle, sealing, standing for 6 months at normal temperature, and observing the appearance change of the emulsion.
No phenomena such as layering, precipitation, color change and the like are observed in the heat resistance test, the cold resistance test and the normal temperature test, and the original appearance is maintained.
Human skin patch test:
Examples 1-4 of the foregoing preparations were referred to the human skin patch test in 2022 cosmetic safety Specification.
Skin reactions were observed as standard at 30min (after the disappearance of the indentations), 24h and 48h, respectively, and the observations were recorded, see table 5.
TABLE 8 human safety test results
Numbering device | 30min | 24h | 48h |
Example 1 | Grade 0, 30 | Grade 0, 30 | Grade 0, 30 |
Example 2 | Grade 0, 30 | Grade 0, 30 | Grade 0, 30 |
Example 3 | Grade 0, 30 | Grade 0, 30 | Grade 0, 30 |
Example 4 | Grade 0, 30 | Grade 0, 30 | Grade 0, 30 |
Subjective evaluation test of cosmetic effect:
a subject: 40 healthy volunteers, sex women, age 45.+ -.2 years, were selected and divided into 4 groups (i.e., skin resident agents prepared in examples 1-4).
The using method comprises the following steps: the prepared liquid cosmetic was applied to the face in the morning and evening every day for 4 weeks. During the test, the volunteer could not change the original facial cleansing pattern and habit. In addition, other cosmetics than the test products could not be used.
The evaluation method comprises the following steps: the subjective evaluation method was used to evaluate the change in facial wrinkles, no change was noted as×, slight change was noted as ①, the reduction in wrinkles was more than ②, and the reduction in wrinkles was noted as ③, and the results are shown in table 9.
Table 9 subjective evaluation results
Analysis of results:
According to experimental results, compared with examples 2-4, the embodiment 1 has obvious wrinkle removing effect, which shows that the composition provided by the invention has good synergistic effect with the compounding of plant extract composition hollyhock flower extract and water cypress branch extract, namely the littoral root callus culture filtrate, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7, acetyl hexapeptide-8, tocopherol (vitamin E) and dipotassium glycyrrhizinate, and the wrinkle removing and resisting effect of the whole formula is improved.
Finally, it should be noted that the above embodiments and comparative examples are only for illustrating the technical solution of the present invention and not for limiting the scope of the present invention, and although the present invention has been described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions may be made to the technical solution of the present invention without departing from the spirit and scope of the technical solution of the present invention.
Claims (8)
1. The composition is characterized by comprising the following components in parts by mass:
0.02-0.08 part of coastal cress callus culture filtrate;
0.0002 to 0.0004 parts of palmitoyl tripeptide-1;
0.00010 to 0.00020 parts of palmitoyl tetrapeptide-7;
0.002-0.006 parts of acetyl hexapeptide-8;
0.1-0.3 parts of tocopherol;
0.05-0.15 part of dipotassium glycyrrhizinate;
0.12-0.15 part of hollyhock flower extract;
0.5-1 part of water cypress branch extract.
2. The composition according to claim 1, characterized by comprising the following components in parts by mass:
0.05 part of coastal cress callus culture filtrate;
palmitoyl tripeptide-1.0003 parts;
0.00015 parts of palmitoyl tetrapeptide-7;
0.004 part of acetyl hexapeptide-8;
0.2 parts of tocopherol;
0.1 part of dipotassium glycyrrhizinate;
0.12-0.15 part of hollyhock flower extract;
0.5-1 part of water cypress branch extract.
3. A wrinkle-removing and anti-wrinkle skin-resident agent comprising the composition according to claim 1 or 2.
4. The wrinkle-removing and anti-wrinkle skin resident agent according to claim 3, wherein the composition according to claim 1 or 2 is added to the wrinkle-removing and anti-wrinkle skin resident agent in an amount of 0.17% to 1.7% by mass.
5. The wrinkle-removing and anti-wrinkle skin resident agent according to claim 3, further comprising an emulsifier, a preservative, a humectant, a pH adjustor, and a solvent.
6. The anti-wrinkle skin resident agent according to claim 5, wherein the emulsifier is at least one of acrylic acid (esters)/C10-30 alkanol acrylate cross-linked polymer, C14-22 alcohol, and C12-20 alkyl glucoside.
7. The anti-wrinkle skin resident agent according to claim 5, wherein the humectant is at least one of glycerin, sodium hyaluronate, squalane, butylene glycol, 1, 2-hexanediol;
the preservative is at least one of p-hydroxyacetophenone, phenoxyethanol and ethylhexyl glycerol;
The pH regulator is at least one of arginine, sodium hydroxide and disodium hydrogen phosphate.
8. The method for preparing the wrinkle-removing and wrinkle-preventing skin resident agent according to any one of claims 3 to 7, comprising the steps of:
(1) Heating a certain amount of preservative, humectant, emulsifier and solvent to 65-85deg.C for dissolving, stirring, homogenizing and mixing, and maintaining the temperature for 20min or more to obtain a mixture;
(2) Cooling the mixture obtained in the step (1) to 40-50 ℃, adding the composition according to the claim 1 or 2 into the mixture, dissolving, stirring, mixing, adding a pH regulator, and regulating the pH value to obtain the skin residence agent for removing wrinkles and resisting wrinkles.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410208886.2A CN118161435B (en) | 2024-02-26 | 2024-02-26 | Wrinkle removing and resisting composition containing coastal cress tissue culture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410208886.2A CN118161435B (en) | 2024-02-26 | 2024-02-26 | Wrinkle removing and resisting composition containing coastal cress tissue culture |
Publications (2)
Publication Number | Publication Date |
---|---|
CN118161435A CN118161435A (en) | 2024-06-11 |
CN118161435B true CN118161435B (en) | 2024-08-23 |
Family
ID=91351586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410208886.2A Active CN118161435B (en) | 2024-02-26 | 2024-02-26 | Wrinkle removing and resisting composition containing coastal cress tissue culture |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118161435B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104042545A (en) * | 2014-06-10 | 2014-09-17 | 刘佰岭 | Age-reducing skin care product aiming at cell gene regeneration and repair |
CN108136027A (en) * | 2015-06-19 | 2018-06-08 | 全球健康方案有限责任公司 | For the delivery system based on vaseline of active constituent |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3061416B1 (en) * | 2016-12-29 | 2021-06-18 | Basf Beauty Care Solutions France Sas | USE OF COCONUT WATER AS AN EXTRACTION SOLVENT |
WO2019074959A1 (en) * | 2017-10-09 | 2019-04-18 | Constance Therapeutics, Inc. | Cannabinoid composition and products including alpha-tocopherol |
CN110314118A (en) * | 2019-07-10 | 2019-10-11 | 湖北省吉美化妆品有限公司 | Have effects that anti-aging, the composition repaired and its preparation method and application |
CN110237006B (en) * | 2019-07-25 | 2022-06-14 | 深圳依云四季文化旅游发展有限公司 | Skin care composition and mask |
CN111714400A (en) * | 2020-07-27 | 2020-09-29 | 广东真丽斯化妆品有限公司 | Cosmetic with anti-aging and repairing effects and preparation method thereof |
CN114306114A (en) * | 2022-02-15 | 2022-04-12 | 深圳市中道美生物科技有限公司 | Four-component peptide/plant composition with anti-wrinkle function |
CN115417843A (en) * | 2022-07-27 | 2022-12-02 | 深圳凯联健康生物科技有限公司 | Compound or composition and application thereof in preparation of product with skin collagen production promoting effect |
-
2024
- 2024-02-26 CN CN202410208886.2A patent/CN118161435B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104042545A (en) * | 2014-06-10 | 2014-09-17 | 刘佰岭 | Age-reducing skin care product aiming at cell gene regeneration and repair |
CN108136027A (en) * | 2015-06-19 | 2018-06-08 | 全球健康方案有限责任公司 | For the delivery system based on vaseline of active constituent |
Also Published As
Publication number | Publication date |
---|---|
CN118161435A (en) | 2024-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109350579B (en) | Whitening cosmetic additive, whitening skin-refreshing lotion and preparation method thereof | |
CN111249215A (en) | Multi-effect whitening and freckle-removing cream and preparation method thereof | |
CN115400065B (en) | Skin care product composition with multiple effects of moisturizing, anti-wrinkle, anti-aging, relieving and repairing and application thereof | |
CN113332227A (en) | Soothing and repairing composition and application thereof in cosmetics | |
CN114588061B (en) | Anti-aging wrinkle-removing composition, preparation method thereof and skin care product | |
CN112641702A (en) | Wrinkle-removing and anti-aging composition and preparation method and application thereof | |
CN115054530B (en) | Skin care composition with moisturizing and anti-aging effects and preparation method thereof | |
CN114224768A (en) | Repairing and anti-aging composition and preparation method thereof | |
WO2023226346A1 (en) | Anti-aging plant extract composition, preparation method therefor and use thereof | |
CN115317429A (en) | Composition containing recombinant collagen and having repairing and relieving effects, eye cream containing composition, preparation method and application | |
CN114288216A (en) | Antioxidant and anti-saccharification composition and preparation method thereof | |
CN110051568A (en) | Anti-ageing composition, anti-ageing cream and preparation method thereof | |
CN117338672A (en) | Anti-aging composition and preparation method and application thereof | |
CN112891243A (en) | Cosmetic containing anti-wrinkle composition and preparation method thereof | |
CN111603404B (en) | Skin care essence containing cell extracting solution and preparation method thereof | |
CN109846798B (en) | Composition for tightening skin and cosmetic containing same | |
CN118161435B (en) | Wrinkle removing and resisting composition containing coastal cress tissue culture | |
CN111658587A (en) | Collagenase inhibitor composition, anti-aging water lotion and preparation method thereof | |
CN116966118A (en) | Composition containing rose extract and application thereof | |
KR102654331B1 (en) | Preparation and application of a fermentation composition with anti-photoaging,calming,cooling effects | |
CN112137937B (en) | Active composition with skin aging delaying function and application thereof | |
CN112545961A (en) | Preparation method of whitening and skin-protecting cosmetic | |
CN113662876A (en) | Polypeptide beautifying essence and preparation method thereof | |
CN111557878A (en) | Essence containing human-like collagen and Cistus umbellatus extract and preparation method thereof | |
CN109431911A (en) | Skin whitening, moisturizing crystalline substance dew and preparation method thereof and tyrosinase inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |